Patient BC1 had stage III breast cancer with histological diagnosis of estrogen receptor (ER)- negative, progesterone receptor (PR)-negative and human epidermal growth factor receptor 2 (HER2/neu)–negative, suggesting an aggressive disease, and had been undergoing chemotherapy and irradiation treatments before the blood sample was drawn. This evidence concerns the gene ERBB2 and breast carcinoma.